Summary

A newer immune-dampening drug appears to effectively quell pain and swelling in joints affected by psoriatic arthritis, a new study says. The injectable drug bimekizumab (Bimzelx) eased psoriatic arthritis for more patients than a slightly older drug from its same class, risankizumab (Skyrizi), researchers reported at the American College of Rheumatology (ACR) conference in Orlando, Florida.

AI summaries can be wrong sometimes—always verify important details using the source article.